Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells

Neurochemistry International

Volumn 74, Issue , 2014, Pages 53-64

  Kwon, Seung Hwan ^a   Ma, Shi Xun ^a   Lee, Seok Yong ^a   Jang, Choon Gon ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

6 Hydroxydopamine; Neuronal cell death; Parkinson's disease; Reactive oxygen species; Sulfuretin

Indexed keywords

ANTIOXIDANT; CASPASE 3; CASPASE 9; CATALASE; CYTOCHROME C; GLUTATHIONE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SULFURETIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; BENZOFURAN DERIVATIVE; FLAVONOID;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOCHONDRION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION; WESTERN BLOTTING; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NERVE CELL; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

BENZOFURANS; CATALASE; CELL DEATH; CELL LINE, TUMOR; FLAVONOIDS; GLUTATHIONE; HUMANS; IN SITU NICK-END LABELING; NEUROBLASTOMA; NEURONS; OXIDOPAMINE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84901809773     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2014.04.016     Document Type: Article

References (62)

1. P.M. Abou-Sleiman, M.M. Muqit, and N.W. Wood Expanding insights of mitochondrial dysfunction in Parkinson's disease Nat. Rev. Neurosci. 7 2006 207 219 (Pubitemid 43292466)
2. R.G. Allen, and M. Tresini Oxidative stress and gene regulation Free Radic. Biol. Med. 28 2000 463 499 (Pubitemid 30110662)
3. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 Suppl. 2004 S18 S25
4. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172 (Pubitemid 32524182)
5. C. Borner The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions Mol. Immunol. 39 2003 615 647 (Pubitemid 35454076)
6. R.E. Burke Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease Pharmacol. Ther. 114 2007 261 277 (Pubitemid 46844843)
7. G. Chen, K.A. Bower, C. Ma, S. Fang, C.J. Thiele, and J. Luo Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death FASEB J. 18 2004 1162 1164 (Pubitemid 39561557)
8. J. Choi, B.J. Yoon, Y.N. Han, K.T. Lee, J. Ha, H.J. Jung, and H.J. Park Antirheumatoid arthritis effect of Rhus verniciflua and of the active component, sulfuretin Planta Med. 69 2003 899 904 (Pubitemid 38005444)
9. M.P. Cunha, M.D. Martin-de-Saavedra, A. Romero, E. Parada, J. Egea, L. Del Barrio, A.L. Rodrigues, and M.G. Lopez Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: involvement of intracellular signaling pathways Neuroscience 238 2013 185 194
10. H.C. Curtius, M. Wolfensberger, B. Steinmann, U. Redweik, and J. Siegfried Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus J. Chromatogr. 99 1974 529 540
11. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 (Pubitemid 37130207)
12. A.J. Davison, N.A. Legault, and D.W. Steele Effect of 6-hydroxydopamine on polymerization of tubulin. Protection by superoxide dismutase, catalase, or anaerobic conditions Biochem. Pharmacol. 35 1986 1411 1417
13. W. Duan, X. Zhu, B. Ladenheim, Q.S. Yu, Z. Guo, J. Oyler, R.G. Cutler, J.L. Cadet, N.H. Greig, and M.P. Mattson P53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism Ann. Neurol. 52 2002 597 606 (Pubitemid 35246863)
14. P. Gee, and A.J. Davison Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions Free Radic. Biol. Med. 6 1989 271 284 (Pubitemid 19076493)
15. Y.Y. Glinka, and M.B. Youdim Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine Eur. J. Pharmacol. 292 1995 329 332
16. M. Gomez-Lazaro, M.F. Galindo, C.G. Concannon, M.F. Segura, F.J. Fernandez-Gomez, N. Llecha, J.X. Comella, J.H. Prehn, and J. Jordan 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA J. Neurochem. 104 2008 1599 1612 (Pubitemid 351316775)
17. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629 (Pubitemid 39006738)
18. K.S. Ha, K.M. Kim, Y.G. Kwon, S.K. Bai, W.D. Nam, Y.M. Yoo, P.K. Kim, H.T. Chung, T.R. Billiar, and Y.M. Kim Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation FASEB J. 17 2003 1036 1047 (Pubitemid 36676390)
19. M.O. Hengartner The biochemistry of apoptosis Nature 407 2000 770 776
20. J. Henning, U. Strauss, A. Wree, J. Gimsa, A. Rolfs, R. Benecke, and U. Gimsa Differential astroglial activation in 6-hydroxydopamine models of Parkinson's disease Neurosci. Res. 62 2008 246 253
21. S. Hunot, F. Boissiere, B. Faucheux, B. Brugg, A. Mouatt-Prigent, Y. Agid, and E.C. Hirsch Nitric oxide synthase and neuronal vulnerability in Parkinson's disease Neuroscience 72 1996 355 363 (Pubitemid 26111202)
22. Y. Ikeda, S. Tsuji, A. Satoh, M. Ishikura, T. Shirasawa, and T. Shimizu Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells J. Neurochem. 107 2008 1730 1740
23. D.S. Jang, E.J. Park, M.E. Hawthorne, J.S. Vigo, J.G. Graham, F. Cabieses, B.D. Santarsiero, A.D. Mesecar, H.H. Fong, R.G. Mehta, J.M. Pezzuto, and A.D. Kinghorn Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (tonka bean) J. Nat. Prod. 66 2003 583 587 (Pubitemid 36617876)
24. W.K. Jeon, J.H. Lee, H.K. Kim, A.Y. Lee, S.O. Lee, Y.S. Kim, S.Y. Ryu, S.Y. Kim, Y.J. Lee, and B.S. Ko Anti-platelet effects of bioactive compounds isolated from the bark of Rhus verniciflua stokes J. Ethnopharmacol. 106 2006 62 69 (Pubitemid 43732486)
25. M.J. Jung, H.Y. Chung, S.S. Kang, J.H. Choi, K.S. Bae, and J.S. Choi Antioxidant activity from the stem bark of Albizzia julibrissin Arch. Pharm. Res. 26 2003 458 462
26. E. Junn, and M.M. Mouradian Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases J. Neurochem. 78 2001 374 383 (Pubitemid 32664419)
27. J.H. Kim, C.H. Jung, B.H. Jang, H.Y. Go, J.H. Park, Y.K. Choi, S.I. Hong, Y.C. Shin, and S.G. Ko Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua stokes Am. J. Chin. Med. 37 2009 609 620
28. M.K. Kim, S.C. Kim, J.I. Kang, H.J. Boo, J.W. Hyun, Y.S. Koh, D.B. Park, E.S. Yoo, J.H. Kang, and H.K. Kang Neuroprotective effects of Carpinus tschonoskii MAX on 6-hydroxydopamine-induced death of PC12 cells Biomol. Ther. (seoul) 18 2010 454 462
29. S.H. Koh, S.H. Kim, H. Kwon, Y. Park, K.S. Kim, C.W. Song, J. Kim, M.H. Kim, H.J. Yu, J.S. Henkel, and H.K. Jung Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3 Brain Res. Mol. Brain Res. 118 2003 72 81 (Pubitemid 37238989)
30. S.M. Kulich, C. Horbinski, M. Patel, and C.T. Chu 6-Hydroxydopamine induces mitochondrial ERK activation Free Radic. Biol. Med. 43 2007 372 383 (Pubitemid 46977632)
31. R. Kumar, A.K. Agarwal, and P.K. Seth Free radical-generated neurotoxicity of 6-hydroxydopamine J. Neurochem. 64 1995 1703 1707
32. S.H. Kwon, S.I. Hong, J.A. Kim, Y.H. Jung, S.Y. Kim, H.C. Kim, S.Y. Lee, and C.G. Jang The neuroprotective effects of Lonicera japonica THUNB. against hydrogen peroxide-induced apoptosis via phosphorylation of MAPKs and PI3K/Akt in SH-SY5Y cells Food Chem. Toxicol. 49 2011 1011 1019
33. S.H. Kwon, J.A. Kim, S.I. Hong, Y.H. Jung, H.C. Kim, S.Y. Lee, and C.G. Jang Loganin protects against hydrogen peroxide-induced apoptosis by inhibiting phosphorylation of JNK, p38, and ERK 1/2 MAPKs in SH-SY5Y cells Neurochem. Int. 58 2011 533 541
34. S.H. Kwon, S.I. Hong, Y.H. Jung, M.J. Kim, S.Y. Kim, H.C. Kim, S.Y. Lee, and C.G. Jang Lonicera japonica THUNB. protects 6-hydroxydopamine-induced neurotoxicity by inhibiting activation of MAPKs, PI3K/Akt, and NF-kappaB in SH-SY5Y cells Food Chem. Toxicol. 50 2012 797 807
35. J.C. Lee, K.T. Lim, and Y.S. Jang Identification of Rhus verniciflua stokes compounds that exhibit free radical scavenging and anti-apoptotic properties Biochim. Biophys. Acta 1570 2002 181 191
36. J.W. Lee, Y.J. Choi, J.H. Park, J.Y. Sim, Y.S. Kwon, H.J. Lee, S.S. Kim, and W.J. Chun 3,4,5-Trihydroxycinnamic acid inhibits lipopolysaccharide-induced inflammatory response through the activation of Nrf2 pathway in BV2 microglial cells Biomol. Ther. (seoul) 21 2013 60 65
37. T.S. Lewis, P.S. Shapiro, and N.G. Ahn Signal transduction through MAP kinase cascades Adv. Cancer Res. 74 1998 49 139 (Pubitemid 28193546)
38. X. Li, L. Song, and R.S. Jope Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis J. Neurosci. 16 1996 5914 5922 (Pubitemid 26313967)
39. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, E.S. Alnemri, and X. Wang Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 1997 479 489 (Pubitemid 27508237)
40. Y. Li, F. Luo, L. Wei, Z. Liu, and P. Xu Knockdown of glycogen synthase kinase 3 beta attenuates 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells Neurosci. Lett. 487 2011 41 46
41. Z.Q. Liang, Y.L. Li, X.L. Zhao, R. Han, X.X. Wang, Y. Wang, T.N. Chase, M.C. Bennett, and Z.H. Qin NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53 Brain Res. 1145 2007 190 203 (Pubitemid 46497982)
42. M.P. Mattson NF-kappaB in the survival and plasticity of neurons Neurochem. Res. 30 2005 883 893
43. M.P. Mattson, and M.K. Meffert Roles for NF-kappaB in nerve cell survival, plasticity, and disease Cell Death Differ. 13 2006 852 860
44. D. Menendez, A. Inga, and M.A. Resnick The expanding universe of p53 targets Nat. Rev. Cancer 9 2009 724 737
45. W.E. Muller, F.J. Romero, S. Perovic, G. Pergande, and P. Pialoglou Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion J. Neurochem. 68 1997 2371 2377 (Pubitemid 27218157)
46. K. Nakaso, S. Ito, and K. Nakashima Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells Neurosci. Lett. 432 2008 146 150
47. M. Ouyang, and X. Shen Critical role of ASK1 in the 6-hydroxydopamine- induced apoptosis in human neuroblastoma SH-SY5Y cells J. Neurochem. 97 2006 234 244
48. J. Pan, G. Wang, H.Q. Yang, Z. Hong, Q. Xiao, R.J. Ren, H.Y. Zhou, L. Bai, and S.D. Chen K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways Mol. Pharmacol. 72 2007 1607 1618 (Pubitemid 350146098)
49. K.Y. Park, G.O. Jung, K.T. Lee, J. Choi, M.Y. Choi, G.T. Kim, H.J. Jung, and H.J. Park Antimutagenic activity of flavonoids from the heartwood of Rhus verniciflua J. Ethnopharmacol. 90 2004 73 79 (Pubitemid 38091689)
50. T.L. Perry, D.V. Godin, and S. Hansen Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33 1982 305 310 (Pubitemid 13119539)
51. V. Ries, C. Henchcliffe, T. Kareva, M. Rzhetskaya, R. Bland, M.J. During, N. Kholodilov, and R.E. Burke Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease Proc. Natl. Acad. Sci. USA 103 2006 18757 18762 (Pubitemid 44913483)
52. L. Rossig, C. Badorff, Y. Holzmann, A.M. Zeiher, and S. Dimmeler Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation J. Biol. Chem. 277 2002 9684 9689 (Pubitemid 34968067)
53. H. Saggu, J. Cooksey, D. Dexter, F.R. Wells, A. Lees, P. Jenner, and C.D. Marsden A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra J. Neurochem. 53 1989 692 697 (Pubitemid 19207359)
54. H. Schroeter, C. Boyd, J.P. Spencer, R.J. Williams, E. Cadenas, and C. Rice-Evans MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide Neurobiol. Aging 23 2002 861 880 (Pubitemid 35217712)
55. M. Schuler, E. Bossy-Wetzel, J.C. Goldstein, P. Fitzgerald, and D.R. Green P53 induces apoptosis by caspase activation through mitochondrial cytochrome c release J. Biol. Chem. 275 2000 7337 7342 (Pubitemid 30146286)
56. M.Y. Song, G.S. Jeong, K.B. Kwon, S.O. Ka, H.Y. Jang, J.W. Park, Y.C. Kim, and B.H. Park Sulfuretin protects against cytokine-induced beta-cell damage and prevents streptozotocin-induced diabetes Exp. Mol. Med. 42 2010 628 638
57. M.Y. Song, G.S. Jeong, H.S. Lee, K.S. Kwon, S.M. Lee, J.W. Park, Y.C. Kim, and B.H. Park Sulfuretin attenuates allergic airway inflammation in mice Biochem. Biophys. Res. Commun. 400 2010 83 88
58. R. Soto-Otero, E. Mendez-Alvarez, A. Hermida-Ameijeiras, A.M. Munoz-Patino, and J.L. Labandeira-Garcia Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease J. Neurochem. 74 2000 1605 1612 (Pubitemid 30163982)
59. K. Tieu, P.C. Ashe, D.M. Zuo, and P.H. Yu Inhibition of 6-hydroxydopamine-induced p53 expression and survival of neuroblastoma cells following interaction with astrocytes Neuroscience 103 2001 125 132 (Pubitemid 32304352)
60. M. Wilhelm, Z. Xu, N.V. Kukekov, S. Gire, and L.A. Greene Proapoptotic Nix activates the JNK pathway by interacting with POSH and mediates death in a Parkinson disease model J. Biol. Chem. 282 2007 1288 1295 (Pubitemid 47076575)
61. B. Xiang, X. Fei, W. Zhuang, Y. Fang, Z. Qin, and Z. Liang Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells Brain Res. 1387 2011 29 38
62. A. Yamamuro, Y. Yoshioka, K. Ogita, and S. Maeda Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells Neurochem. Res. 31 2006 657 664 (Pubitemid 43886413)